|
Pfizer Limited names Kewal Handa - Managing Director
 Mumbai, April 21, 2005 - Pfizer today announced that Kewal Handa has been appointed as Managing Director, Pfizer Limited, India. Prior to this, Kewal served as Executive Director - Finance, Pfizer Limited.
.
During his fifteen years with the company, Kewal Handa has been entrusted with positions of increasing responsibility. He has a broad range of experience and has risen above his portfolio as Chief Financial Officer (CFO) by being a key contributor to shaping the future of Pfizer. He has demonstrated leadership and excellence in strategically guiding Pfizer Limited through two mergers with Parke Davis - Warner Lambert (India) Private Limited and Pharmacia respectively.
Kewal is recognized as an industry expert on issues concerning the pharmaceutical sector. As Chairman of the Pricing Committee of the Organisation of Pharmaceutical Producers of India (OPPI), he has been at the forefront of the industry's efforts to resolve issues pertaining to the pharmaceutical sector.
Kewal is also a Committee Member of the Confederation of Indian Industry (CII), Indian Pharmaceutical Alliance (IPA) and the Bombay Chamber of Commerce and Industry (BCCI). He currently serves as President of the Bombay Management Association (BMA). He was recently awarded the ‘ India CFO 2004-Excellence in Finance in MNC' by the International Market Assessment Group.
Kewal holds a Masters Degree in Commerce from Sydenham College, Mumbai. He is also a qualified Management Accountant and a Company Secretary.
He succeeds Hocine Sidi Said as the leader of the Pfizer's India operations. Hocine Sidi Said had spent four years in India as Managing Director.
|
